CBUS
Cibus Global LLC
NASDAQ: CBUS · HEALTHCARE · BIOTECHNOLOGY
$1.40
+9.37% today
Updated 2026-04-30
Market cap
$114.42M
P/E ratio
—
P/S ratio
31.44x
EPS (TTM)
$-2.78
Dividend yield
—
52W range
$1 – $4
Volume
0.7M
Cibus Global LLC (CBUS) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-1,273.00%
ROE
-221.00%
ROA
-12.90%
Debt/equity
0.67x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2015 | $1.27M | $-5.89M | 40.96% | -457.08% | -462.97% |
| 2016 | $399000.00 | $-12.09M | 49.87% | -3,034.84% | -3,029.07% |
| 2017 | $508000.00 | $-25.98M | -8.46% | -5,076.57% | -5,114.17% |
| 2018 | $236000.00 | $-27.90M | -358.05% | -11,913.14% | -11,820.76% |
| 2019 | $7.30M | $-39.61M | -27.19% | -543.76% | -542.93% |
| 2020 | $23.85M | $-44.84M | -47.28% | -183.77% | -187.98% |
| 2021 | $25.99M | $-29.20M | -9.89% | -112.87% | -112.36% |
| 2022 | $157000.00 | $-16.89M | 100.00% | -14,248.41% | -10,758.60% |
| 2023 | $1.82M | $-267.63M | 78.26% | -17,549.97% | -14,729.06% |
| 2024 | $4.26M | $-251.39M | 100.00% | -6,062.79% | -5,898.36% |
| 2025 | $3.64M | $-127.08M | -62.76% | -1,853.92% | -3,492.31% |